Welcome to our dedicated page for TransDigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransDigm Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransDigm Group's regulatory disclosures and financial reporting.
Form 144 Notice for TransDigm Group Inc (TDG) shows a proposed sale of 9,000 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value reported as $11,484,613.00. The shares were acquired by the seller via an option exercise on 11/08/2017 (65,000 shares acquired) and the planned sale date is listed as 08/20/2025 with payment noted as cash. The filing also discloses three recent sales by the same person during the past three months—3,000 shares on 05/20/2025, 06/20/2025 and 07/21/2025—with gross proceeds of $4,303,050.00, $4,272,803.00 and $4,793,579.00 respectively. The filer affirms no undisclosed material adverse information and signs under Rule 144 attestation requirements.
TransDigm Group Incorporated reported that its wholly owned subsidiary TransDigm Inc. amended its senior credit agreement on September 17, 2025. The company repriced the margin on $1,686 million of existing term loans K from Term SOFR plus 2.75% to Term SOFR plus 2.25%. It also amended and extended $1,857 million of existing term loans I, pushing the maturity from August 2028 to March 2030 and reducing the margin on these loans from Term SOFR plus 2.75% to Term SOFR plus 2.25% by converting them into new tranche K term loans. Other terms and conditions of the new tranche K loans remain substantially the same as before the amendment.
TransDigm Group Inc. director W. Nicholas Howley reported multiple transactions in the issuer's common stock on 09/15/2025. The filing shows an acquisition of 2,736 shares via exercise related to a stock option with an adjusted exercise price of $50.92. The reporting person also sold a series of batches totaling 2,736 shares at weighted prices in a range from approximately $1,273.69 to $1,288.21. Following these transactions, the reporting person (through the W. Nicholas Howley Family Trust u/a/d 4/23/99) is shown as beneficially owning 21,547.513 shares of TransDigm common stock.
Robert J. Small, a director of TransDigm Group Inc. (TDG), reported multiple transactions in the company’s common stock on Form 4. The filing shows indirect holdings of 441,814 shares by Stockbridge Fund, L.P. and 60,246 shares held by family trusts. On 09/12/2025 several sales by Stockbridge Partners LLC are reported at weighted-average prices ranging approximately from $1,270.85 to $1,284.35 across multiple blocks. The filing also discloses a 09/15/2025 gift of 10,000 shares to a donor-advised fund (reported as $0 consideration). The reporting person disclaims direct beneficial ownership of the shares held by the entities named.
TransDigm Group Inc. (TDG) Form 144 notice: The filer proposes to sell Common Stock through two brokers, Goldman, Sachs & Co. and Barclays Bank PLC, each listed with 10,000 shares to be sold on or about 09/12/2025 on the NYSE. Each 10,000-share entry shows an aggregate market value of $12,873,200.00 and the issuer's outstanding shares listed as 56,350,285. The securities were acquired by open market purchases on 12/31/2017 for 10,000 shares and paid in cash on that date. The filer reports no securities sold in the past three months and includes the standard attestation that they are not aware of undisclosed material adverse information.
TransDigm Group Inc. (TDG) Form 4: Robert J. Small, a company director and managing member of related investment entities, reported transactions dated 09/02/2025. The filing shows dispositions of Common Stock totaling 17,899 shares (2,318 and 15,581 shares) at a reported price of $0 (reflecting distributions rather than market sales). After the transactions, the reporting person (indirectly) is shown as beneficially owning 441,814 shares via Stockbridge Fund, plus 88,419 shares via Stockbridge Partners LLC and 60,246 shares via managed accounts, with additional family trust holdings. The reporting person disclaims beneficial ownership except for any pecuniary interest.
TransDigm Group Inc. insider activity: Director Michael Graff executed a stock option and completed related open-market sales on 08/26/2025. Mr. Graff exercised an option for 1,760 shares with an adjusted exercise price of $156.47 and immediately sold 1,760 shares in multiple transactions at weighted average prices in ranges between $1,398.79 and $1,404.42, with reported average weighted sale prices noted per lot. Following these transactions his direct beneficial ownership is reported as 1,964 shares. He also reports indirect holdings of 7,000 shares held by certain trusts he manages and 5,096 shares held by a separate trust created by his spouse.
TransDigm Group Incorporated (TDG) notice reports a proposed sale of 1,760 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $2,467,687.38. The filing shows the shares were acquired on 08/26/2025 by exercise of options under a registered plan, consisting of 820 and 940 shares respectively, with cash payment on the same date. The filer certifies no undisclosed material adverse information about the issuer and indicates no securities sold by the person in the prior three months.
Joel Reiss, Co-Chief Operating Officer of TransDigm Group (TDG), reported insider transactions on 08/20/2025. He exercised stock options to acquire 3,000 shares at an exercise price of $284.97, then sold a total of 3,000 common shares in multiple blocks at weighted average prices in the approximate ranges of $1,399.40–$1,413.60. After these transactions the reporting person beneficially owned 3,600 common shares directly. The filing also shows beneficial ownership of 53,000 shares underlying stock options exercisable through 11/08/2027. The report indicates the transactions were made pursuant to a written plan consistent with Rule 10b5-1.
TransDigm Group Incorporated filed an 8-K reporting material agreements dated August 19, 2025. The filing includes indentures and forms for two note issuances: a 6.250% Senior Secured Note due 2034 and a 6.750% Senior Subordinated Note due 2034. Both indentures reference TransDigm Inc. as issuer with TransDigm Group Incorporated and subsidiary guarantors as applicable.
The company also disclosed Amendment No. 18 and an Incremental Term Loan Assumption Agreement, dated August 19, 2025, to its Second Amended and Restated Credit Agreement (originally dated June 4, 2014). A press release dated August 20, 2025, and the cover page interactive XBRL file are included as exhibits. The filing is signed by Sarah Wynne.